NASDAQ · IPSC
Century Therapeutics, Inc.
Healthcare · Biotechnology
$1.48
Down-$0.16 (-10.81%)
Updated Oct 7, 2026, 1:02 AM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 50.91M
- P/E ratio
- -2.19
- Dividend yield
- 0.00%
- 52-week range
- $0.44 – $3.04
- Volume
- 773.85K
- Avg. volume
- 989.38K
Price performance · IPSC
IPSC price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
IPSC closed at $1.48 after 20 trading sessions, down 28.50% for the selected period.
- Last close
- $1.48
- Period change
- -28.50%
- Period low
- $1.48
- Period high
- $2.07
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.58 | $1.59 | $1.4545 | $1.48 | 773.85K |
| Oct 2, 2026 | $1.64 | $1.67 | $1.465 | $1.53 | 802.96K |
| Oct 1, 2026 | $1.65 | $1.695 | $1.595 | $1.61 | 622.51K |
| Sep 30, 2026 | $1.67 | $1.72 | $1.66 | $1.71 | 624.21K |
| Sep 29, 2026 | $1.66 | $1.67 | $1.63 | $1.65 | 353.52K |
| Sep 28, 2026 | $1.66 | $1.715 | $1.62 | $1.67 | 409.14K |
| Sep 25, 2026 | $1.70 | $1.78 | $1.63 | $1.67 | 456.96K |
| Sep 24, 2026 | $1.77 | $1.77 | $1.68 | $1.69 | 545.26K |
| Sep 23, 2026 | $1.89 | $1.938 | $1.76 | $1.76 | 508.11K |
| Sep 22, 2026 | $1.88 | $1.94 | $1.85 | $1.89 | 414.14K |
| Sep 21, 2026 | $1.87 | $1.905 | $1.8285 | $1.85 | 421.02K |
| Sep 18, 2026 | $1.88 | $1.88 | $1.815 | $1.86 | 1.37M |
| Sep 17, 2026 | $1.89 | $1.94 | $1.83 | $1.88 | 430.19K |
| Sep 16, 2026 | $2.00 | $2.06 | $1.86 | $1.86 | 839.47K |
| Sep 15, 2026 | $2.00 | $2.00 | $1.93 | $1.98 | 359.64K |
| Sep 14, 2026 | $1.96 | $2.02 | $1.89 | $2.00 | 507.6K |
| Sep 11, 2026 | $1.98 | $2.00 | $1.89 | $1.94 | 465.71K |
| Sep 10, 2026 | $2.03 | $2.03 | $1.91 | $1.94 | 510.03K |
| Sep 9, 2026 | $2.07 | $2.10 | $2.03 | $2.03 | 293.08K |
| Sep 8, 2026 | $2.10 | $2.13 | $2.03 | $2.07 | 228.15K |
Latest IPSC news
The latest Smart Investors Daily articles mentioning IPSC.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

